In vivo labeling of delta opioid receptors in mouse brain by [3H]benzylidenenaltrexone, a ligand selective for the delta1 subtype

Life Sciences

Volumn 58, Issue 21, 1996, Pages

  Lever, John R ^a,b   Stathis, Marigo ^a   Kinter, Chris M ^a   Scheffel, Ursula ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Benzylidenenaltrexone; Delta opioid receptors; Naltriben

Indexed keywords

MURINAE; ANIMALIA;

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 7 BENZYLIDENENALTREXONE; CYPRODIME; DELTA 1 OPIATE RECEPTOR; DELTA 2 OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; KAPPA OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; NALTRIBEN; NALTRINDOLE; RADIOLIGAND; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BINDING COMPETITION; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG RECEPTOR BINDING; DRUG UPTAKE; INTRAVENOUS DRUG ADMINISTRATION; ISOMER; LIGAND BINDING; MALE; MOUSE; NONHUMAN; OLFACTORY NUCLEUS; RECEPTOR DENSITY; STEREOSPECIFICITY; TISSUE DISTRIBUTION;

ANIMALS; BENZYLIDENE COMPOUNDS; CORPUS STRIATUM; MALE; MICE; NALTREXONE; RADIOLIGAND ASSAY; RECEPTORS, OPIOID, DELTA; TRITIUM;

EID: 15844429510     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00175-0     Document Type: Article

References (20)

1. R.S. RAPAKA and F. PORRECA, Pharmacol. Res. 8 1-8 (1991).
2. E.E. ABDELHAMID, M. SULTANA, P.S. PORTOGHESE and A.E. TAKEMORI, J. Pharmacol. Exp. Ther. 258 299-303 (1991).
3. D.N.C. JONES and S.G. HOLTZMAN, J. Pharmacol. Exp. Ther. 262 638-645 (1992).
4. T. SUZUKI, T. MORI, M. TSUJI, M. MISAWA and H. NAGASE, Life Sci. 55 PL 339-344 (1994).
5. K. MENKENS, E.J. BILSKY, K.D. WILD, P.S. PORTOGHESE, L.D. REID and F. PORRECA, Eur. J. Pharmacol. 219 345-346 (1992).
6. D.J. CALCAGNETTI, B.J. KECK, L.A. QUATRELLA and M.D. SCHECHTER, Life Sci. 56 475-483 (1995).
7. E. ACQUAS, M. MELONI and G. DI CHIARA, Eur. J. Pharmacol. 230 239-241 (1993).
8. J.J. RADY, A.E. TAKEMORI, P.S. PORTOGHESE and J.M. FUJIMOTO, Life Sci. 55 603-609 (1994).
9. R.J. KNAPP and H.I. YAMAMURA, Biochem Pharmacol 44 1687-1695 (1992).
10. P.S. PORTOGHESE, M. SULTANA and A.E. TAKEMORI, J. Med. Chem. 33 1714-1720 (1990).
11. J.R. LEVER, C.M. KINTER, H.T. RAVERT, J.L. MUSACHIO, W.B. MATHEWS and R.F. DANNALS, J. Labelled Compds. Radiopharm. 36 137-145 (1995).
12. J.R. LEVER, U. SCHEFFEL, C.M. KINTER, H.T. RAVERT, R.F. DANNALS, H.N. WAGNER JR. and J.J. FROST, Eur. J. Pharmacol. 216 459-460 (1992).
13. I. MADAR, J.R. LEVER, C.M. KINTER, U. SCHEFFEL, H.T. RAVERT, J.L. MUSACHIO, W.B. MATHEWS, R.F. DANNALS and J.J. FROST, Synapse, in press.
14. J.R. TRAYNOR and J. ELLIOTT, Trends Pharmacol. Sci. 14 84-86 (1993).
15. A.E. TAKEMORI and P.S. PORTOGHESE, Eur. J. Pharmacol. 242 145-150 (1993).
16. P.S. PORTOGHESE, M. SULTANA, H. NAGASE and A.E. TAKEMORI, Eur. J. Pharmacol. 218 195-196 (1992).
17. S. DUPIN, J.A.M. TAFANI, H. MAZARGUIL and J.-M. ZAJAC, Peptides 12 825-830 (1991).
18. P. DELAY-GOYET, M. RUIZ-GAYO, A. BAAMONDE, G. GACEL, J.-L. MORGAT and B.P. ROQUES, Pharmacol. Biochem. Behav. 38 155-162 (1991).
19. R.B. RAFFA, R.P. MARTINEZ and F. PORRECA, Eur. J. Pharmacol. 216 453-456 (1992).
20. S. CHAKRABARTI, M. SULTANA, P.S. PORTOGHESE and A.E. TAKEMORI, Life Sci. 53 1761-1765 (1993).